Evaluate the mechanisms by which patented technology is licensed, transferred and commercialised, and apply royalty and valuation frameworks to a commercialisation decision.
Lecture 1 covered the two mechanisms that transfer ownership. This lecture covers the third — licensing, which does not — and the wider process of technology transfer that surrounds it.
Sections 2—8 are licensing; Sections 9—14 are technology transfer and commercialisation. The two halves are joined by one idea: a licence is a personal privilege, not a transfer of title. The licensee obtains exactly what the agreement enumerates and nothing else.
Section 7 contains the numerical work. Be able to compute a royalty under each structure — it appears on the paper as a calculation, and the three worked examples are the model.
1. Learning Outcomes
- Define patent licensing and distinguish it from assignment.
- Compare exclusive, non-exclusive and sole licences across exclusivity, royalty magnitude and risk.
- Identify the principal clauses of a licensing agreement and explain the commercial risk each addresses.
- Compute royalties under lump-sum, running, per-unit, milestone and minimum-floor structures.
- Differentiate the eight mechanisms by which patented technology moves from laboratory to market.
- Apply TRL assessment, market sizing and the three valuation methods to a commercialisation decision.
2. Conceptual Foundations of Patent Licensing
Patent licensing is the contractual act of granting permission to use a patented invention. Legally, a licence is a personal privilege: it does not transfer ownership of the patent. The patentee retains title, and the licensee obtains only those rights expressly enumerated in the agreement.
This is the fundamental distinction from assignment, which is a complete transfer of ownership — the subject of Lecture 1.
The statutory basis treats patents as movable property that may be licensed, assigned or mortgaged: Section 68 onwards of the Indian Patents Act, 1970; 35 U.S.C. §261; and Article 73 of the European Patent Convention.
2.1 Six Objectives Licensing Serves
- Revenue generation through royalties and fees.
- Market expansion by leveraging the licensee’s established distribution channels.
- Risk sharing, particularly where commercialisation requires substantial capital investment.
- Standardisation — enabling coordinated use of patents essential to industry standards such as 5G and Wi-Fi.
- Defensive monetisation to deter litigation.
- Technology diffusion and societal benefit, particularly in university and public-sector contexts.
Software-related inventions, communication protocols and hardware designs are typically patented but rarely commercialised through in-house production alone. The value lies in adoption across an ecosystem — which licensing enables and assignment does not.
3. Types of Patent Licence
Licences are categorised along three axes: exclusivity, scope (territorial and field-of-use), and duration. The commercially decisive dimension is exclusivity, producing the canonical trilogy.
3.1 Exclusive Licence
Grants the licensee the sole right to practise the patent within a defined territory and field of use, to the exclusion of all other parties — including the licensor. Ownership remains with the patentee, but the licensor is contractually barred from exercising those rights or granting further licences.
Five characteristics: only one licensee holds the right; the licensor is excluded from commercial use within the agreed scope; the licensee is usually required to meet performance milestones to maintain exclusivity; the licensee usually has the right to sue infringers in its own name; and it is the most valuable to the licensee and therefore the most expensive to obtain.
Typical use: university spin-out commercialisation; pharmaceutical licensing of a blockbuster molecule; semiconductor foundries licensing process patents from a fabless design house. In computing, common in specialised embedded systems, AI accelerators and proprietary database engines.
An exclusive licensee who lacks incentive to commercialise broadly can simply sit on the invention. This is why performance milestones, minimum annual royalties and reversion clauses exist, and why they matter especially to a university licensor.
3.2 Non-Exclusive Licence
Permits the licensee to use the patent while the licensor retains the right to grant similar licences to others and to use the patent itself. There is no restriction on the number of licensees.
Characteristics: any number of licensees may hold parallel rights; the licensor continues to practise; royalty rates are lower because the exclusivity premium is absent; used where the patent covers an industry standard or where the licensor seeks maximum diffusion.
Typical use: standard-essential patents licensed through pools such as MPEG-LA and Sisvel; codecs, image formats and communication protocols (H.264/AVC, H.265/HEVC, 4G LTE); open specifications where multiple implementations must coexist.
Non-exclusive licensing is the dominant model for standard-essential patents precisely because interoperability requires that everyone be able to implement the standard. The FRAND commitment — fair, reasonable and non-discriminatory terms — is what a holder gives in exchange for having its technology written into a standard.
IBM historically generated over $1 billion annually from patent licensing by offering non-exclusive licences across its semiconductor and software portfolio.
3.3 Sole Licence
A hybrid. The licensor grants the licensee the right to practise, retains its own right to practise, but undertakes not to grant additional licences to any third party. Only two parties may practise: the licensor and the sole licensee. The licensee does not enjoy the right to exclude the licensor.
Typical use: joint research arrangements where one party retains background rights and grants a sole licence over foreground developments; manufacturing arrangements where the patent owner also produces competing goods.
3.4 Comparative Summary
| Dimension | Exclusive | Sole | Non-exclusive |
|---|---|---|---|
| Number of licensees | One | One | Unlimited |
| Licensor may practise | No | Yes | Yes |
| Licensor may license further | No | No | Yes |
| Royalty magnitude | Highest | Intermediate | Lowest |
| Risk to licensor | Highest | Intermediate | Lowest |
Can the licensor still practise? No for exclusive; yes for sole and non-exclusive.
Can the licensor license again? No for exclusive and sole; yes for non-exclusive.
3.5 Four Related Structures
- Cross-licence. Two or more parties exchange licences to their respective patents. Widespread in high technology where firms hold dense, overlapping portfolios — the smartphone “peace” agreements are the canonical example.
- Compulsory licence. Imposed by a State authority in defined public-interest circumstances — non-working in the territory, semiconductor technology under specific national laws, or a government-use notification. The COVID-19 vaccine landscape brought these powers to international attention.
- Patent pool licence. A single licence bundling patents owned by different entities, typical for standards-implementing technologies.
- Sublicence. A licence granted by an existing licensee to a third party. It requires explicit authorisation in the primary licence; it is never implied.
4. The Licensing Agreement — Operative Clauses
4.1 Recitals and Definitions
Establishes the parties, the background and intent, and a definitions subsection. Definitions must be unambiguous and exhaustive — particularly “Licensed Product”, “Licensed Process”, “Territory”, “Field of Use”, “Net Sales”, “Affiliate” and “Effective Date”. “Net Sales” deserves particular care: it is the base on which every running royalty is computed.
4.2 The Grant Clause
The operative provision. It must specify which patents are licensed (by number, country and family); whether the licence is exclusive, sole or non-exclusive; whether sublicensing rights are granted and on what conditions; the field of use; and the territory.
The grant clause is the most heavily litigated provision in any licence. Under customary principles of contract interpretation, ambiguity in the scope of the grant almost always favours the licensee. If you are the licensor, every word you leave vague is a word a court will read against you.
4.3 Consideration and Royalty Provisions
Specifies the financial consideration, framed by reference to one of the royalty structures in Section 7.
5. Protective Clauses
Read the following as a risk allocation rather than legal furniture. Each clause addresses a specific commercial exposure.
| Clause | Content | Risk addressed |
|---|---|---|
| Performance obligations | Minimum sales or production volumes by set dates; commercially reasonable efforts; minimum annual royalties; progress reports. Failure triggers reversion of rights | Shelving by an unmotivated licensee |
| Improvements and derivatives | Licensor ownership with assignment; licensee ownership with licence-back; or joint ownership — common in university–industry work | Losing the next generation of the technology to your own licensee |
| Reporting and auditing | Periodic royalty reports showing units, net revenue, royalties due and currency; licensor retains annual audit rights | Under-reporting of sales |
| Warranties and indemnities | Warranty of title; warranty of non-infringement of third-party rights — often heavily contested | Third-party claims against the licensee |
| Term and termination | Duration, renewal, termination for breach or insolvency, post-termination sell-off rights | Being locked into a failing relationship |
| Confidentiality | Protects the know-how transferred alongside the patent | Disclosure of unpublished technical knowledge |
| Governing law and disputes | Choice of law, forum, and whether disputes go to arbitration — the norm in cross-border agreements | Jurisdictional uncertainty |
6. Royalty Structures
A royalty is the consideration paid by the licensee in exchange for the licensed rights. The structure determines the cash-flow profile, the allocation of risk, and the incentives embedded in the deal.
6.1 Six Structures
- Lump-sum payment. A single fixed payment at the outset or on a milestone. Advantages: certainty, no ongoing accounting, simplicity. Disadvantages: does not scale with licensee success; overpayment risk if the product fails. Typical uses: university patent licensing, one-time software access fees, early-stage transfer to established firms.
- Running royalty. A periodic royalty as a fixed percentage of the net sales price. Advantages: scales with revenue, aligns incentives. Disadvantages: requires monitoring and audit. Typical range: in software and ICT licensing, 1% to 12% of net sales, depending on the technology’s contribution, exclusivity and market position.
- Per-unit royalty. A fixed monetary amount per unit sold — USD 0.50 per device, INR 1.00 per chip. Advantages: simplicity, easy verification. Disadvantages: does not capture value changes from price inflation or premium positioning. Typical uses: codec licensing, semiconductor IP.
- Milestone payments. Linked to specific events — regulatory approval, first commercial sale, sales thresholds, development stages. Requires clear, objective milestones, or the clause becomes the dispute.
- Minimum annual royalties. A floor below which the licensee must pay regardless of actual sales. Characteristic of exclusive licences; the principal defence against under-utilisation.
- Combination models. Most contemporary agreements are hybrid: a small upfront lump sum, plus milestone payments, plus a running royalty, plus a minimum annual royalty.
7. Royalty Calculation
7.1 The Formula
where R is the total royalty owed, S the net sales of the licensed product over the relevant period, and r the royalty rate as a decimal (0.05 for five percent). Where a minimum floor applies, the period royalty becomes:
7.2 Two Problems the Formula Creates
Problem 1 — the base. When the licensed product incorporates many technologies, on what do you charge the percentage? The market and the courts answer with the smallest saleable patent-practising unit (SSPPU), which limits the licensor’s claim to the contribution of its own technology alone.
Problem 2 — stacking. Where many licensors each demand a percentage of the total product price, the combined burden can exceed commercially sustainable levels. Three market responses: patent pools, aggregate royalty caps and the SSPPU base.
7.3 Three Worked Examples
A software firm licenses a patented data compression engine from a university. Non-exclusive, royalty rate 4% of net sales. The licensee sells 250,000 units at a net price of INR 800 per unit in Year 1.
R = 250,000 × 800 × 0.04 = INR 8,000,000
A chipset manufacturer licenses an error-correction technology at INR 1.20 per unit with a minimum annual royalty of INR 5,000,000. The licensee produces 3,500,000 units.
Computed royalty = 3,500,000 × 1.20 = 4,200,000Minimum royalty = 5,000,000Royalty due (the higher) = INR 5,000,000
Note what this teaches: the licensee paid 800,000 more than its sales warranted. That is the floor doing exactly the job the licensor drafted it to do.
A robotics start-up licenses an obstacle-detection patent from a research institute: upfront lump sum INR 4,000,000; milestone on first commercial sale INR 2,000,000; running royalty 3% of net sales; minimum annual royalty after Year 2 of INR 1,500,000.
In Year 1 the start-up records first commercial sale (milestone triggered), then sells 50,000 units at a net price of INR 25,000 each.
Milestone payment = 2,000,000Running royalty = 50,000 × 25,000 × 0.03 = 37,500,000Total Year 1 royalty = INR 39,500,000 (the minimum annual does not yet apply)
7.4 Ten Factors Influencing the Rate
Royalty rates are negotiated outcomes, not statutory values. The principal determinants are the nature of the technology (foundational technologies command more); the stage of development; exclusivity; field of use; market size and growth prospects; available alternatives and the ease of design-around; the risk and development cost borne by the licensee; standards-essentiality, which is FRAND-constrained; strategic significance such as blocking a competitor; and comparable industry benchmarks.
7.5 Tax Treatment
Royalties are treated as royalty income in the country of receipt and are subject to withholding tax at source. International licensing is affected by Double Taxation Avoidance Agreements. Whether a payment is classified as “royalty” or “business income” materially affects taxation and is frequently contested in audits — so the characterisation belongs in the agreement.
8. Licensing and Computer Software
The intersection of patent law and software is jurisdictionally uneven. Software as such is not patentable in many jurisdictions in the way it is in the United States after Alice Corp. v. CLS Bank International (2014), although software implemented as part of a technical solution is patentable under Sections 3(k) and 10 of the Indian Patents Act and Articles 52(2) and (3) of the EPC.
Despite this unevenness, the dominant IP regime for software worldwide remains copyright, with patent protection layered on top for specific technical innovations — the subject of Lecture 4.
9. Technology Transfer — Concepts
The lifecycle of an invention does not end at grant. The patent is merely the legal instrument that enables the owner to control how the invention enters the market. The actual movement of a protected invention from laboratory to productive commercial use is technology transfer.
Technology transfer is the silent engine behind nearly every product you use: the video codec in your streaming service, the instruction set in your processor, the cryptographic primitives securing your transactions, the machine-learning libraries powering your applications. Most originated in research environments and reached the public through deliberate transfer mechanisms — not by accident.
| Term | Definition |
|---|---|
| Technology transfer (TT) | The formal or informal process of conveying technical knowledge, skills, processes or materials from one organisation to another for development, application or commercialisation |
| Technology transfer agreement (TTA) | A legally binding contract defining the terms under which technology is transferred between transferor and transferee |
| Know-how | Unpatented technical knowledge, often tacit, that supports the practical application of a patented invention |
| Technology readiness level (TRL) | A 9-point scale assessing maturity from basic research (TRL 1) to proven deployment (TRL 9) |
| Technology transfer office (TTO) | A specialised unit, typically within a university, responsible for managing IP and facilitating commercialisation |
10. Eight Mechanisms of Technology Transfer
10.1 Mechanisms That Move Ownership or Rights
- Licensing — the most widely used. The owner retains ownership and grants permission to make, use, sell or import, in exchange for consideration. Forms: exclusive, sole, non-exclusive, cross-licence.
- Assignment — an outright sale. Ownership transfers permanently. Under Section 69, assignments must be registered with the Controller to be valid against third parties; an unregistered assignment is void against any person claiming under a subsequent assignee for consideration. Common in acquisitions of startups, inheritance and restructuring, and university-to-startup transfers.
- Joint ventures and strategic alliances — two or more parties pool resources. Used where the technology requires complementary assets, where neither party can commercialise alone, or where risk-sharing is desired. Example: Intel and Micron co-developed 3D XPoint memory through the IM Flash Technologies joint venture, with cross-licensed patents enabling the partnership.
- Spin-offs and start-ups — a new company founded to commercialise a specific technology, often from a university lab. The founding institution typically holds equity, licenses the relevant patents to the spin-off, and provides initial funding and incubation. Example: Google grew out of Stanford’s PageRank research.
10.2 Mechanisms That Transfer Access or Knowledge
- Contract and sponsored research — an external sponsor funds specific research in exchange for defined rights to resulting IP. Terms, typically negotiated by the TTO, cover ownership of foreground IP, licence-back rights to the institution, and publication rights.
- Material transfer agreements (MTAs) — govern the transfer of tangible materials or restricted datasets under defined conditions. Increasingly relevant in software research where the “material” is a proprietary dataset or model.
- Franchising and technical assistance — franchising transfers a complete business model including patents, trademarks and know-how; technical assistance agreements provide consulting and engineering support, usually combined with licensing.
- Open source and patent pools — open-source licensing operates on copyright, but many projects depend on patents for technical implementation. Patent pools aggregate complementary patents for collective licensing. SEPs for 4G LTE, 5G NR and Wi-Fi 6 are commercialised through FRAND pools; the MPEG LA pool licenses the patents essential to H.264.
In sponsored research, the publication-rights clause determines whether and for how long a sponsor may delay your paper. It is negotiable, and it is routinely signed unread.
11. Technology Transfer Agreements
A TTA is the contractual foundation of any transfer involving IP. The principal clauses are:
- Parties. Transferor (often a TTO, corporation or individual inventor) and transferee. For university-originated patents the transferor is the institution, with the inventor named in a recital clause.
- Subject matter and definitions. Precise identification of the patents, know-how and materials transferred.
- Grant of rights. Scope, exclusivity, field of use and territory.
- Consideration. Upfront payment; milestone payments; running royalties, commonly 2–8% in software and 1–5% in pharmaceuticals; minimum annual royalties; and a sublicensing revenue share retained by the licensor.
- Improvements and foreground IP. Who owns inventions made by the licensee during the term that rely on the licensed technology: sole licensee ownership, joint ownership, or mandatory licence-back.
- Sublicensing. Common in distribution-heavy industries; heavily restricted in exclusive university licences.
- Performance milestones, with reversion on failure.
- Infringement and enforcement. Who has the right and the duty to sue, who bears the cost, and how recoveries are divided.
- Warranties, indemnities and disclaimers; term, termination and post-termination rights; confidentiality; dispute resolution; and compliance with law, including export control.
12. Commercialisation — Readiness and Market
12.1 Technology Readiness Assessment
The TRL framework, developed by NASA and now standard at research-funding agencies including India’s DST, provides a common metric.
| TRL | Description | Phase |
|---|---|---|
| 1 | Basic principles observed | Research |
| 2 | Technology concept formulated | |
| 3 | Experimental proof of concept | |
| 4 | Validated in the laboratory | Development — the commercialisation window |
| 5 | Validated in a relevant environment | |
| 6 | Demonstrated in a relevant environment | |
| 7 | System prototype demonstration | Deployment |
| 8 | System complete and qualified | |
| 9 | System proven in an operational environment |
Commercialisation typically begins in earnest at TRL 4–6 — when the invention is mature enough to interest licensees. Below TRL 4 there is nothing to demonstrate; above TRL 6 the institution has usually spent capital it will struggle to recover through royalties alone.
12.2 Market Assessment
A commercialisation plan must answer four questions: who is the customer — end user, OEM or integrator; what is the value proposition — what problem does the invention solve better than alternatives; what is the addressable market — quantified as TAM (total addressable), SAM (serviceable addressable) and SOM (serviceable obtainable); and what is the competitive landscape — existing patents, prior art and substitute technologies.
13. Patent Valuation and Go-to-Market
13.1 Three Valuation Methods
(a) Cost approach. Estimates the cost to develop a substitute. Useful for early-stage technologies where future revenue is uncertain.
(b) Market approach. Uses comparable transactions — recent patent sales in the same technology class. Challenging in software because of rapid obsolescence.
(c) Income approach. The most rigorous: project future cash flows attributable to the patent and discount them to present value.
where FCFt is the free cash flow attributable to the patent at time t, WACC the weighted average cost of capital, and Vtangible the value of tangible assets.
In practice royalties are often benchmarked using the 25% Rule: the licensee should retain approximately 75% of the operating profit attributable to the licensed technology, with the licensor taking the remaining quarter. It is a rule of thumb rather than law — but it anchors many real negotiations.
13.2 Five Go-to-Market Routes
- Out-licensing to an established firm — low capital requirement, faster market entry. The default for a university with no manufacturing capacity.
- Spin-off formation — higher potential return, higher risk and capital requirement.
- Cross-licensing with a partner — useful when technologies are interdependent.
- Patent assertion — aggressive, litigation-driven monetisation, common among non-practising entities. Effective, and reputationally costly for an academic institution.
- Standards contribution — embedding the patented technology into an industry standard, generating FRAND royalty streams at scale. The highest-leverage route in ICT, and the slowest.
The choice is driven by three variables: how much capital the owner can deploy, how mature the technology is, and whether an incumbent already wants it. A university at TRL 4 with no industry interest is choosing between route 2 and shelving the invention.
14. Summary
- A licence is a personal privilege — permission to use, with ownership retained.
- Exclusive, sole and non-exclusive differ on two questions: can the licensor practise, and can it license again.
- Non-exclusive licensing plus FRAND is what makes interoperability standards possible.
- The grant clause is the most litigated provision, and ambiguity favours the licensee.
- Royalty structures combine; the minimum floor is the licensor’s defence against shelving.
- SSPPU and patent pools are the market’s answer to royalty stacking.
- Technology transfer runs through eight mechanisms; the choice follows capital, TRL and incumbent interest.
- Commercialisation begins at TRL 4–6; valuation uses cost, market or income approaches.
15. Exam Preparation
- Prepare the comparative table of exclusive, sole and non-exclusive licences and memorise the dimensions.
- For each royalty type, be able to construct a numerical worked example.
- Map each clause of a licensing agreement to the commercial risk it addresses.
- Connect licensing concepts to the FRAND regime in standard-essential patents.
- Relate open-source licensing (GPL, Apache) to patent grant clauses — this is frequently asked.
- Distinguish licensing from assignment, exclusive from sole, and TTAs from MTAs.
- Be ready to explain and write the income-approach formula.
- Know Sections 69 (registration of assignments) and 70 (co-ownership) of the Patents Act.
- Practise advising a hypothetical client on whether to license, assign or spin off a technology.
15.1 Short-Answer Questions
- Differentiate between an exclusive and a sole patent licence. Can a sole licensee sue an infringer independently? 3 marks
- What is a “running royalty”? State the formula and explain each variable. 3 marks
- State any three clauses commonly included in a patent licensing agreement. 3 marks
- What is the smallest saleable patent-practising unit, and why is it commercially relevant? 3 marks
- Differentiate licensing from assignment in patent law. 3 marks
- Explain the role of a minimum annual royalty in an exclusive patent licence. 2 marks
- State the purpose of an audit clause in a licensing agreement. 2 marks
- What is a FRAND commitment, and how does it affect royalty levels for SEPs? 3 marks
- What is royalty stacking, and how do patent pools mitigate it? 3 marks
- Why are improvement clauses typically included in technology licensing agreements? 2 marks
- What is the purpose of a diligence clause in a TTA? 2 marks
- Explain the 25% Rule in patent valuation. 2 marks
- List any four functions of a technology transfer office. 2 marks
15.2 Long-Answer and Analytical Questions
- Compare and contrast the three principal types of patent licence. Illustrate your answer with a hypothetical scenario drawn from the ICT sector. 12 marks
- Examine the principal clauses of a well-drafted patent licensing agreement. Explain why each is important from either the licensor’s or the licensee’s perspective. 12 marks
- Discuss the principal royalty structures available in patent licensing, using a numerical illustration for at least three of them. 12 marks
- Explain the principal clauses of a technology transfer agreement. Why are field-of-use and territory clauses particularly important in international TTAs? 10 marks
- “Licensing is more advantageous than assignment for a university holding a patent.” Discuss. 10 marks
- Discuss the eight mechanisms of technology transfer, and advise which is most appropriate for a university-owned algorithm at TRL 4 with no incumbent interest. 12 marks
15.3 Applied Exercise
A university licenses your project’s algorithm at 5% of net sales with a minimum annual royalty of INR 200,000. Year 1 sales are 3,000 units at INR 1,200 each.
(a) Compute the royalty due. (b) Decide whether the licence should be exclusive, and justify your answer in two sentences with reference to shelving risk and the university’s objectives.
16. Suggested Reading
- The Patents Act, 1970 — read Sections 68, 69, 70 and Chapter XIX directly.
- 35 U.S.C. §261 and Article 73 of the European Patent Convention — the statutory basis for treating patents as transferable property.
- WIPO. Exchanging Value: Negotiating Technology Licensing Agreements — A Training Manual.
- AUTM. Technology Transfer Practice Manual. Association of University Technology Managers.
- Georgia-Pacific Corp. v. United States Plywood Corp. (1970) — the fifteen factors for reasonable royalty.
- Microsoft Corp. v. Motorola, Inc. (W.D. Wash. 2013) — FRAND royalty determination and the SSPPU approach.
- NASA / DST. Technology Readiness Level definitions.
- ISO 56005:2020, Innovation management — Tools and methods for intellectual property management.